HELIUS MEDICAL TECHNOLOGIE-A (HSDT) Stock Income Statement
NASDAQ:HSDT - Nasdaq - US42328V8019 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 520.00K | 644.00K | 787.00K | 520.00K | 660.00K | |||
| Cost Of Goods | 582.00K | 583.00K | 463.00K | 300.00K | 390.00K | |||
| Gross Profit | -62.00K | 61.00K | 324.00K | 220.00K | 270.00K | |||
| Operating Expenses | 13.80M | 12.33M | 15.08M | 18.34M | 14.35M | |||
| Research and Development | 3.66M | 2.94M | 4.26M | 5.99M | 4.58M | |||
| Selling, General, and Administrative Expenses | 10.12M | 9.27M | 10.64M | 12.16M | 9.40M | |||
| Operating Income | -13.86M | -12.27M | -14.76M | -18.12M | -14.08M | |||
| Interest Income/Expense | 1.96M | 3.50M | 1.44M | 10.00K | 190.00K | |||
| Other Income/Expense | 203.00K | 80.00K | 7.00K | 0.00 | 60.00K | |||
| Non Recurring Items | -40.00K | -159.00K | -757.00K | -20.00K | -310.00K | |||
| Income Before Taxes | -11.74M | -8.85M | -14.07M | -18.13M | -14.13M | |||
| Income Tax | 0.00 | 0.00 | N/A | N/A | N/A | |||
| Net Income | -11.74M | -8.85M | -14.07M | -18.13M | -14.13M | |||
| EBITDA | -13.80M | -12.11M | -14.50M | -17.81M | -13.60M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.33 | -14.56 | -52.13 | -362.60 | -706.50 | |||
| Non GAAP EPS | -5.73 | -14.46 | -116.00 | -6.35 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | -11.92% | 9.47% | 41.17% | 42.31% | 40.91% | |||
| Profit Margin | -2258.08% | -1374.22% | -1788.06% | -3486.54% | -2140.91% | |||
| Operating Profit Margin | -2665.96% | -1905.12% | -1875.35% | -3484.62% | -2133.33% | |||
All data in USD